Skip to content

Berlin: Orphan Drugs Access And Economics Masterclass

March 28, 2015




Mark your calendars: Berlin, Germany, will be the location of Fleming Europe’s pharmaceutical event, Orphan Drugs Access and Economics Masterclass, scheduled for June 9 – 10, 2015.

“Rare disease therapies would be highly unattractive under standard market conditions from an investor perspective. The small number of patients cannot financially justify expending resources into orphan therapy research and development, which is a long, expensive, and risky process. As the population of patients with a specific rare disease is very small, the investments must be recouped by increasing the price of the product. It has been acknowledged that, while regulatory incentives have stimulated research and development of orphan therapies on a global level, equitable and timely access to approved orphan medicinal products for rare disease patients remains an issue. Decisions on Pricing and Reimbursement are the exclusive competence of the Member States of the European Union …”


•   EU Regulation, Programs, & Mechanisms for Orphan Medicinal Products

•   Achieving Sustainable Access For Orphan Drugs

•   Methods for Economic Evaluation of Orphan Drugs

•   Alternative Ways to Raise Funds & Finance Orphan Drugs

•   Regulatory, Pricing & Reimbursement

•   Patients & Payers

•   Alternative Models: Drug Repurposing.

Speaker Panel

·   Carlos R. Camozzi, Chief Medical Officer, Orphazyme

·   Günter Harms, Market Access & Public Affairs Director, Shire

·   Camille Métais, Associate Director – Regulatory Affairs, Alexion Pharma International

·   Luis Cruz, General Manager Spain & Portugal, CSL Behring.

Please reference the Meeting Agenda for detail information, visit the website, or contact Martina Hrabinska at

Please Note: “Writing Hand” by gnuckx (Flickr: Roma Italy – Creative Commons by gnuckx) [Public domain or CC-BY-2.0] | Wikimedia Commons.

Copyright © 2012-2015, Orphan Druganaut Blog. All rights reserved.

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: